158 related articles for article (PubMed ID: 23637845)
1. Pharmacokinetics and interspecies allometric scaling of ST-246, an oral antiviral therapeutic for treatment of orthopoxvirus infection.
Amantana A; Chen Y; Tyavanagimatt SR; Jones KF; Jordan R; Chinsangaram J; Bolken TC; Leeds JM; Hruby DE
PLoS One; 2013; 8(4):e61514. PubMed ID: 23637845
[TBL] [Abstract][Full Text] [Related]
2. Safety and pharmacokinetics of the antiorthopoxvirus compound ST-246 following repeat oral dosing in healthy adult subjects.
Jordan R; Chinsangaram J; Bolken TC; Tyavanagimatt SR; Tien D; Jones KF; Frimm A; Corrado ML; Pickens M; Landis P; Clarke J; Marbury TC; Hruby DE
Antimicrob Agents Chemother; 2010 Jun; 54(6):2560-6. PubMed ID: 20385870
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the safety and pharmacokinetics of ST-246® after i.v. infusion or oral administration in mice, rabbits and monkeys.
Chen Y; Amantana A; Tyavanagimatt SR; Zima D; Yan XS; Kasi G; Weeks M; Stone MA; Weimers WC; Samuel P; Tan Y; Jones KF; Lee DR; Kickner SS; Saville BM; Lauzon M; McIntyre A; Honeychurch KM; Jordan R; Hruby DE; Leeds JM
PLoS One; 2011; 6(8):e23237. PubMed ID: 21858040
[TBL] [Abstract][Full Text] [Related]
4. Safety and pharmacokinetics of the anti-orthopoxvirus compound ST-246 following a single daily oral dose for 14 days in human volunteers.
Chinsangaram J; Honeychurch KM; Tyavanagimatt SR; Leeds JM; Bolken TC; Jones KF; Jordan R; Marbury T; Ruckle J; Mee-Lee D; Ross E; Lichtenstein I; Pickens M; Corrado M; Clarke JM; Frimm AM; Hruby DE
Antimicrob Agents Chemother; 2012 Sep; 56(9):4900-5. PubMed ID: 22777041
[TBL] [Abstract][Full Text] [Related]
5. Single-dose safety and pharmacokinetics of ST-246, a novel orthopoxvirus egress inhibitor.
Jordan R; Tien D; Bolken TC; Jones KF; Tyavanagimatt SR; Strasser J; Frimm A; Corrado ML; Strome PG; Hruby DE
Antimicrob Agents Chemother; 2008 May; 52(5):1721-7. PubMed ID: 18316519
[TBL] [Abstract][Full Text] [Related]
6. Oral Tecovirimat for the Treatment of Smallpox.
Grosenbach DW; Honeychurch K; Rose EA; Chinsangaram J; Frimm A; Maiti B; Lovejoy C; Meara I; Long P; Hruby DE
N Engl J Med; 2018 Jul; 379(1):44-53. PubMed ID: 29972742
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic comparison of a single oral dose of polymorph form i versus form V capsules of the antiorthopoxvirus compound ST-246 in human volunteers.
Chinsangaram J; Honeychurch KM; Tyavanagimatt SR; Bolken TC; Jordan R; Jones KF; Marbury T; Lichtenstein I; Pickens M; Corrado M; Landis P; Clarke JM; Frimm AM; Hruby DE
Antimicrob Agents Chemother; 2012 Jul; 56(7):3582-6. PubMed ID: 22526314
[TBL] [Abstract][Full Text] [Related]
8. Molecule of the month. Tecovirimat.
Drug News Perspect; 2008 Nov; 21(9):517. PubMed ID: 19180269
[No Abstract] [Full Text] [Related]
9. Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virus.
Smith SK; Self J; Weiss S; Carroll D; Braden Z; Regnery RL; Davidson W; Jordan R; Hruby DE; Damon IK
J Virol; 2011 Sep; 85(17):9176-87. PubMed ID: 21697474
[TBL] [Abstract][Full Text] [Related]
10. Towards a better prediction of peak concentration, volume of distribution and half-life after oral drug administration in man, using allometry.
Sinha VK; Vaarties K; De Buck SS; Fenu LA; Nijsen M; Gilissen RA; Sanderson W; Van Uytsel K; Hoeben E; Van Peer A; Mackie CE; Smit JW
Clin Pharmacokinet; 2011 May; 50(5):307-18. PubMed ID: 21456631
[TBL] [Abstract][Full Text] [Related]
11. ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification.
Jordan R; Goff A; Frimm A; Corrado ML; Hensley LE; Byrd CM; Mucker E; Shamblin J; Bolken TC; Wlazlowski C; Johnson W; Chapman J; Twenhafel N; Tyavanagimatt S; Amantana A; Chinsangaram J; Hruby DE; Huggins J
Antimicrob Agents Chemother; 2009 May; 53(5):1817-22. PubMed ID: 19223621
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacokinetics of Racivir, (+/-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine in rats, rabbits, dogs, monkeys and HIV-infected humans.
Hurwitz SJ; Otto MJ; Schinazi RF
Antivir Chem Chemother; 2005; 16(2):117-27. PubMed ID: 15889534
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Human Pharmacokinetics of Ulixertinib, a Novel ERK1/2 Inhibitor from Mice, Rats, and Dogs Pharmacokinetics.
Suresh PS; Jairam RK; Chandrasekhar DV; Vinod AB; Hiremath RA; Raj A; Zainuddin M; Bhamidipati RK; Mullangi R
Eur J Drug Metab Pharmacokinet; 2018 Aug; 43(4):453-460. PubMed ID: 29470718
[TBL] [Abstract][Full Text] [Related]
14. Interspecies comparison of the pharmacokinetics of aldose reductase inhibitors.
Brazzell RK; Park YH; Wooldridge CB; McCue B; Barker R; Couch R; York B
Drug Metab Dispos; 1990; 18(4):435-40. PubMed ID: 1976064
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey.
Adams WJ; McGovren JP; Dalm EA; Brewer JE; Hosley JD
Cancer Res; 1989 Nov; 49(22):6328-36. PubMed ID: 2529962
[TBL] [Abstract][Full Text] [Related]
16. Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
Deguchi T; Watanabe N; Kurihara A; Igeta K; Ikenaga H; Fusegawa K; Suzuki N; Murata S; Hirouchi M; Furuta Y; Iwasaki M; Okazaki O; Izumi T
Drug Metab Dispos; 2011 May; 39(5):820-9. PubMed ID: 21282406
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of tecovirimat (ST-246) in nonhuman primates infected with variola virus (Smallpox).
Mucker EM; Goff AJ; Shamblin JD; Grosenbach DW; Damon IK; Mehal JM; Holman RC; Carroll D; Gallardo N; Olson VA; Clemmons CJ; Hudson P; Hruby DE
Antimicrob Agents Chemother; 2013 Dec; 57(12):6246-53. PubMed ID: 24100494
[TBL] [Abstract][Full Text] [Related]
18. Predicting oral clearance in humans: how close can we get with allometry?
Sinha VK; De Buck SS; Fenu LA; Smit JW; Nijsen M; Gilissen RA; Van Peer A; Lavrijsen K; Mackie CE
Clin Pharmacokinet; 2008; 47(1):35-45. PubMed ID: 18076217
[TBL] [Abstract][Full Text] [Related]
19. Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
Bae SK; Lee SJ; Kim YG; Kim SH; Kim JW; Kim T; Lee MG
Biopharm Drug Dispos; 2005 Apr; 26(3):99-115. PubMed ID: 15723427
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice.
Quenelle DC; Buller RM; Parker S; Keith KA; Hruby DE; Jordan R; Kern ER
Antimicrob Agents Chemother; 2007 Feb; 51(2):689-95. PubMed ID: 17116683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]